Australia markets closed

Staar Surgical Co (SR3.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
43.26-0.15 (-0.35%)
At close: 08:14PM CEST
Full screen
Previous close43.41
Open43.43
Bid43.17 x 200000
Ask43.43 x 200000
Day's range43.14 - 43.43
52-week range24.83 - 52.12
Volume0
Avg. volume0
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings date31 July 2024 - 05 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Investor's Business Daily

    Staar Surgical Stock Earns RS Rating Upgrade

    Staar Surgical shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 77 to 87.

  • Zacks

    Staar Surgical (STAA) Soars 7.5%: Is Further Upside Left in the Stock?

    Staar Surgical (STAA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

  • Business Wire

    STAAR Surgical to Participate in Goldman Sachs 45th Annual Global Healthcare Conference

    LAKE FOREST, Calif., June 05, 2024--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, invites investors and the general public to listen to a webcast fireside chat with Patrick F. Williams, Chief Financial Officer, at the upcoming Goldman Sachs 45th Annual Global Healthcare Conference, which will be held in Miami, Florida.